Jul 1, 1977

Agranulocytosis after antiarrhythmic therapy with ajmalin (author's transl)

Zeitschrift für Kardiologie
R SpielM Fischer

Abstract

A case of agranulocytosis (min. leucocyte count 980/mm3) after 4 weeks of treatment with an ajmalin derivate is reported. Recovery could be achieved by taking away the antiarrhythmic drug. It appears that these agranulocytoses only happen after a dosage of more than 300 mg/die, and that they have an intermediate position between allergic and toxic agranulocytosis (phenothiazine type).

  • References
  • Citations

References

  • We're still populating references for this paper, please check back later.
  • References
  • Citations

Citations

  • This paper may not have been cited yet.

Mentioned in this Paper

Phenothiazine
White Blood Cell Count Procedure
Anti-Arrhythmia Agents
Antiarrhythmic [EPC]
Atrial Fibrillation
Tachmalin
Phenothiazine Measurement
Atrial Flutter
Phenothiazine [EPC]
Agranulocytosis

About this Paper

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

Deutsche medizinische Wochenschrift
H Engel
The Medical Journal of Australia
F C Firkin, A F Mariani
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris
J BarrierC Larousse
© 2020 Meta ULC. All rights reserved